Héla Karray
- Otorhinolaryngology top 5%
- Infectious Diseases top 10%
- Parvovirus B19 Infection Studies 5
- SARS-CoV-2 and COVID-19 Research 4
-
- Viral-associated cancers and disorders 10
-
- Hepatitis C virus research 7
- Hepatitis Viruses Studies and Epidemiology 4
-
- Hepatitis B Virus Studies 8
- Respiratory viral infections research 8
- Virology and Viral Diseases 4
Héla Karray
42 papers receiving 497 citations
Peers
Comparison fields: 5 of 81
- Otorhinolaryngology 84
- Infectious Diseases 143
- Oncology 201
- Hepatology 42
- Pathology and Forensic Medicine 77
Countries citing papers authored by Héla Karray
This map shows the geographic impact of Héla Karray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Héla Karray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Héla Karray more than expected).
Fields of papers citing papers by Héla Karray
This network shows the impact of papers produced by Héla Karray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Héla Karray. The network helps show where Héla Karray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Héla Karray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 7 | |
| 8 | 2018 | 20 | |
| 9 | 2016 | 6 | |
| 10 | 2012 | 19 | |
| 11 | 2010 | 13 | |
| 12 | 2010 | 12 | |
| 13 | 2009 | 19 | |
| 14 | 2009 | 12 | |
| 15 | 2009 | 12 | |
| 16 | 2007 | 21 | |
| 17 | 2006 | 16 | |
| 18 | 2005 | 56 | |
| 19 | [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)]. | 2001 | 29 |
| 20 | [Epidemiology of hepatitis C virus infection and circulating genotypes in the Sfax region--Tunisia]. | 1999 | 0 |
About Héla Karray
Héla Karray is a scholar working on Hepatology, Infectious Diseases, Otorhinolaryngology, Epidemiology and Applied Microbiology and Biotechnology, having authored 48 papers that have together received 520 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (10 papers), Hepatitis B Virus Studies (8 papers), Respiratory viral infections research (8 papers), Hepatitis C virus research (7 papers), Parvovirus B19 Infection Studies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Virology and Viral Diseases (4 papers) and Hepatitis Viruses Studies and Epidemiology (4 papers). The work is most often cited by research in Otorhinolaryngology (84 citations), Infectious Diseases (143 citations), Oncology (201 citations), Hepatology (42 citations) and Pathology and Forensic Medicine (77 citations). Héla Karray has collaborated with scholars based in Tunisia, France and Switzerland. Frequent co-authors include Adnane Hammami, Mounir Frikha, Jamel Daoud, Abdelmajid Khabir, T. Boudawara, R Jlidi, J. Daoud, M. Frikha, Jaap M. Middeldorp and Wajdi Ayadi. Their work appears in journals such as Virology, Journal of Medical Virology, International Journal of Infectious Diseases, Cancer Treatment Reviews and BMC Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.